Schonfeld Strategic Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $695K | Sell |
3,564
-13,676
| -79% | -$2.83M | ﹤0.01% | 1681 |
|
|
2026
Q1 | $3.87M | Buy |
+17,240
| New | +$4.3M | 0.03% | 574 |
|
|
2025
Q4 | – | Sell |
-5,806
| Closed | -$1.59M | – | 2516 |
|
|
2025
Q3 | $1.59M | Buy |
+5,806
| New | +$1.59M | 0.01% | 1158 |
|
|
2025
Q2 | – | Sell |
-10,527
| Closed | -$2.36M | – | 2461 |
|
|
2025
Q1 | $2.36M | Buy |
+10,527
| New | +$2.46M | 0.01% | 884 |
|
|
2024
Q3 | – | Sell |
-2,402
| Closed | -$460K | – | 2361 |
|
|
2024
Q2 | $460K | Buy |
+2,402
| New | +$487K | ﹤0.01% | 1524 |
|
|
2023
Q4 | – | Sell |
-8,740
| Closed | -$1.29M | – | 2165 |
|
|
2023
Q3 | $1.29M | Sell |
8,740
-23,166
| -73% | -$4.19M | 0.01% | 937 |
|
|
2023
Q2 | $6.97M | Buy |
+31,906
| New | +$7.11M | 0.06% | 423 |
|
|
2023
Q1 | – | Sell |
-15,834
| Closed | -$3.3M | – | 2564 |
|
|
2022
Q4 | $3.3M | Buy |
15,834
+14,628
| +1,213% | +$3.21M | 0.03% | 629 |
|
|
2022
Q3 | $263K | Buy |
+1,206
| New | +$274K | ﹤0.01% | 2168 |
|
|
2022
Q1 | – | Sell |
-5,600
| Closed | -$1.46M | – | 2877 |
|
|
2021
Q4 | $1.46M | Buy |
5,600
+2,700
| +93% | +$701K | 0.01% | 790 |
|
|
2021
Q3 | $764K | Buy |
+2,900
| New | +$793K | 0.01% | 1074 |
|
|
2021
Q2 | – | Sell |
-5,100
| Closed | -$990K | – | 2248 |
|
|
2021
Q1 | $990K | Buy |
+5,100
| New | +$1.02M | 0.01% | 896 |
|
|
2020
Q4 | – | Sell |
-25,000
| Closed | -$4.29M | – | 1834 |
|
|
2020
Q3 | $4.29M | Buy |
+25,000
| New | +$4.62M | 0.08% | 333 |
|
|
2020
Q2 | – | Sell |
-1,816
| Closed | -$267K | – | 1514 |
|
|
2020
Q1 | $267K | Buy |
+1,816
| New | +$289K | 0.02% | 799 |
|
|
2019
Q2 | – | Sell |
-6,400
| Closed | -$666K | – | 1217 |
|
|
2019
Q1 | $666K | Buy |
6,400
+4,604
| +256% | +$475K | 0.02% | 616 |
|
|
2018
Q4 | $205K | Sell |
1,796
-9,104
| -84% | -$975K | 0.01% | 937 |
|
|
2018
Q3 | $1.26M | Buy |
+10,900
| New | +$1.19M | 0.06% | 381 |
|
|
2018
Q2 | – | Sell |
-3,626
| Closed | -$357K | – | 932 |
|
|
2018
Q1 | $357K | Sell |
3,626
-9,627
| -73% | -$910K | 0.03% | 547 |
|
|
2017
Q4 | $1.12M | Buy |
+13,253
| New | +$1.09M | 0.09% | 285 |
|
|
2016
Q2 | – | Sell |
-12,910
| Closed | -$746K | – | 519 |
|
|
2016
Q1 | $746K | Buy |
+12,910
| New | +$731K | 0.3% | 93 |
|
Other funds holding RMD
Schonfeld Strategic Advisors's RMD Position: Q2 2026 in Review
Schonfeld Strategic Advisors reduced its ResMed (RMD) stake by 79% in Q2 2026, selling an estimated $2.83M and leaving 3,564 shares worth $695K. The position accounts for ﹤0.01% of the portfolio, ranked #1681.
Schonfeld Strategic Advisors first reported a position in RMD in Q1 2016 and has held it in 20 quarters since. The position peaked at $6.97M in Q2 2023. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Schonfeld Strategic Advisors held 3,564 shares of ResMed worth $695K as of Q2 2026.
- Schonfeld Strategic Advisors sold 13,676 ResMed shares in Q2 2026, an estimated $2.83M.
- ResMed made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1681 holding.
- Schonfeld Strategic Advisors first reported a position in ResMed in Q1 2016 and has held it in 20 quarters since.
- Schonfeld Strategic Advisors's ResMed position peaked at $6.97M in Q2 2023.
- 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.